You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

histone deacetylase inhibitor

Showing 1 - 25 of 7,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin's Lymphoma Trial in Milan (histone deacetylase inhibitor (ITF2357))

Terminated
  • Hodgkin's Lymphoma
  • histone deacetylase inhibitor (ITF2357)
  • Milan, Italy
    Istituto Nazionale per lo studio e la cura dei Tumori
Jan 18, 2022

Hodgkin's Lymphoma Trial in Milano (ITF2357)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Milano, Italy
    Istituto Nazionale per la Cura e lo Studio dei Tumori
Apr 20, 2021

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Multiple Myeloma Trial in Cagliari (ITF2357)

Terminated
  • Multiple Myeloma
  • Cagliari, Italy
    Presidio Ospedaliero R. Binaghi
Jan 18, 2022

Safety and Efficacy Trial in Guangzhou, Wuhan (Sintilimab, Chidamide)

Completed
  • Safety and Efficacy
  • Guangzhou, Guangdong, China
  • +3 more
Apr 6, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Multiple Myeloma Trial in United States (ACY-1215, lenalidomide, Dexamethasone)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 7, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Diffuse Large B Cell Lymphoma Trial (Pembrolizumab and CXD101)

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • Pembrolizumab and CXD101
  • (no location specified)
Aug 12, 2021

Cervical Cancer, Cervix Cancer, Cervix Tumor Trial in Guangzhou (Toripalimab + Chidamide)

Recruiting
  • Cervical Cancer
  • +2 more
  • Toripalimab + Chidamide
  • Guangzhou, 广东, China
    Sun Yat-sen University Cancer Centre
Dec 3, 2020

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021

Peripheral T-cell Lymphoma Trial in Shanghai (PD-1 antibody+ HDAC inhibitor)

Recruiting
  • Peripheral T-cell Lymphoma
  • PD-1 antibody+ HDAC inhibitor
  • Shanghai, Shanghai, China
    Dongmei Ji
Dec 3, 2021

Angioimmunoblastic T-cell Lymphoma Trial in Guangzhou (Sintilimab, Chidamide)

Not yet recruiting
  • Angioimmunoblastic T-cell Lymphoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Apr 2, 2021

Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Romidepsin, Cisplatin, Nivolumab)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Breast Cancer
  • Fairway, Kansas
  • +6 more
Nov 19, 2021

Multiple Myeloma Trial in Worldwide (ACY-241, Pomalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +24 more
Dec 15, 2022

Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,

Completed
Has Results
  • Brain Stem Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +20 more
Jan 6, 2023

Lymphoid Malignancies, Lymphoma, Hodgkin Lymphoma Trial in New York (Romidepsin, Oral 5-Azacitidine)

Terminated
  • Lymphoid Malignancies
  • +3 more
  • New York, New York
    Columbia University Medical Center
Jan 5, 2021

Active Systemic, Onset Juvenile Idiopathic Arthritis Trial in Bucharest, Niš, Belgrade (ITF2357)

Completed
Has Results
  • Active Systemic
  • Onset Juvenile Idiopathic Arthritis
  • Bucharest, Romania
  • +4 more
Apr 8, 2021

Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

Recruiting
  • Heart Failure With Normal Ejection Fraction
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 1, 2022

Smoldering Multiple Myeloma Trial in Boston, Durham, Cleveland (Hiltonol, Citarinostat, Lenalidomide)

Recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Feb 22, 2021

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
Has Results
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Lymphoma, Follicular Trial in China (Abexinostat)

Recruiting
  • Lymphoma, Follicular
  • Beijing, China
  • +25 more
Mar 3, 2022

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023